Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression

Neoplasma

Volumn 60, Issue 6, 2013, Pages 598-604

  Guo, Q ^a,b   Nan, X X ^a   Yang, J R ^a   Yi, L ^a   Liang, B L ^a   Wei, Y B ^a   Zhu, N ^a   Hu, S B ^a   Zhang, H ^b   Luo, Y ^b   Xu, Y F ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Third Hospital of Changsha   (China)

Author keywords

Apoptosis; MDR1; Multidrug resistance; Prostate cancer; Triptolide

Indexed keywords

CYCLIN D1; DOXORUBICIN; FAS ANTIGEN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; TRIPTOLIDE; ABCB1 PROTEIN, HUMAN; ALKYLATING AGENT; DITERPENE; EPOXIDE; MULTIDRUG RESISTANCE PROTEIN; PHENANTHRENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MTT ASSAY; MULTIDRUG RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CYCLE; DRUG EFFECT; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; DITERPENES; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; EPOXY COMPOUNDS; HUMANS; MALE; P-GLYCOPROTEIN; PHENANTHRENES; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84887549941     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_077     Document Type: Article

References (22)

1. WILSON KM, GIOVANNUCCI EL, MUCCI LA. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl. 2012; 14: 365-374. http://dx.doi.org/10.1038/aja.2011.142
2. GUMULEC J, MASARIK M, KRIZKOVA S, HLAVNA M, BABULA P, et al. Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers. Neoplasma. 2012; 59: 191-201. http://dx.doi.org/10.4149/neo_2012_025
3. SIVONOVA MK, DOBROTA D, MATAKOVA T, DUSENKA R, GROBARCIKOVA S, et al. Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population. Neoplasma. 2012; 59: 79-84. http://dx.doi.org/10.4149/neo_2012_010
4. JAMASPISHVILI T, SCORILAS A, KRAL M, KHOMERIKI I, KURFURSTOVA D, et al. Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients. Neoplasma. 2011; 58: 298-303.
5. LI Y, YUAN H, YANG K, XU W, TANG W, et al. The structure and functions of P-glycoprotein. Curr Med Chem. 2010; 17: 786-800. http://dx.doi.org/10.2174/092986710790514507
6. ZUBERCOVA O, BABUSIKOVA O. The multidrug resistance in human leukemias. Neoplasma. 1998; 45: 53-59.
7. EICHHORN T, EFFERTH T. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol. 2012; 141: 557-570. http://dx.doi.org/10.1016/j.jep.2011.08.053
8. LIU Q. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol. 2011; 11: 377-383. http://dx.doi.org/10.1016/j.intimp.2011.01.012
9. ZHU W, LI J, WU S, LI S, LE L, et al. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer. Pancreas. 2012; 41: 1029-1038. http://dx.doi.org/10.1097/MPA.0b013e31824abdc0
10. LIU Y, SONG F, WU WK, HE M, ZHAO L, et al. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct. 2012; 30: 271-278. http://dx.doi.org/10.1002/cbf.2793
11. LI CJ, CHU CY, HUANG LH, WANG MH, SHEU LF, et al. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 2012; 319: 203-213. http://dx.doi.org/10.1016/j.canlet.2012.01.006
12. XIAOWEN H, YI S. Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 upregulation. Mol Biol Rep. 2012; 39: 8763-8770. http://dx.doi.org/10.1007/s11033-012-1737-2
13. DAI CL, LIANG YJ, CHEN LM, ZHANG X, DENG WJ, et al. Sensitization of ABCB1 overexpression cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Biochem Pharmacol 2009; 78: 355-364. http://dx.doi.org/10.1016/j.bcp.2009.04.023
14. OZKAYA S, FINDIK S, ATICI AG, DIRICA A. Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients. Neoplasma 2011; 58: 348-351. http://dx.doi.org/10.4149/neo_2011_04_348
15. OZKAN M, BERK V, KAPLAN MA, BENEKLI M, COSKUN U, et al. Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience. Neoplasma 2012; 59: 38-42. http://dx.doi.org/10.4149/neo_2012_005
16. STACEY DW. CYCLIN D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol. 2003; 15: 158-163. http://dx.doi.org/10.1016/S0955-0674(03)00008-5
17. HUANG W, ZHANG H, ZOU K, CHEN J, LI X, et al. Total saponins of Tupistra chinensis induces apoptosis in A549 cells. Neoplasma 2012; 59: 613-621. http://dx.doi.org/10.4149/neo_2012_078
18. CHEN YW, LIN GJ, CHUANG YP, CHIA WT, HUENG DY, et al. Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells. Anticancer Drugs. 2010; 21: 502-513. http://dx.doi.org/10.1097/CAD.0b013e328337337c
19. LI H, HUI L, XU W, SHEN H, CHEN Q, et al. Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells. Oncol Lett. 2012; 3: 485-489.
20. LIN X, ZHANG X, WANG Q, LI J, ZHANG P, et al. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line. Neoplasma. 2012; 59: 248-256. http://dx.doi.org/10.4149/neo_2012_032
21. KIM MJ, LEE TH, KIM SH, CHOI YJ, HEO J, et al. Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway. Int J Oncol. 2010; 37: 1177-1185. http://dx.doi.org/10.3892/ijo_00000769
22. YOSHIDA N, TAKAGI A, KITAZAWA H, KAWAKAMI J, ADACHI I. Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus. Toxicol Appl Pharmacol 2005; 209: 167-173. http://dx.doi.org/10.1016/j.taap.2005.04.001